Evernoa - Model Base -Exhaled Biomarkers
FromeverSens
Evernoa Base allows to measure the Fraction of Exhaled nitric oxide (FeNO) present in human breath. This biomarker provides in a minimally invasive, fast and simple way relevant information about airway inflammation. This information is useful in the diagnosis and monitoring of inflammatory respiratory diseases, such as asthma.
Most popular related searches
airway inflammation
fractional exhaled nitric oxide
respiratory disease
biomarker
asthma
inflammatory disease
patient interface
asthma monitoring
Point-of-care, portable, rapid and highly accurate FeNO device that facilitates the diagnosis and monitoring of asthma by providing useful information on airway inflammation.
- Easy to set up and use
- Accurate and results in 5 seconds
- Dual user interface
- According to ATS/ERS recommendations
- Software connectivity
- No need to inhale through the device
- Adults / 10"
- Training* / Selectable from 2" to 10"
- Children / 6"
- Exterior / (Ambient NO measure)
- The healthcare professional selects the operation mode
- The healthcare professional explains to the patient how the exhalation process works.
- The patient inhales ambien air and exhales trhough the mouthpiece. A LED interface helps patient in the exhalation process.
- Results are available in 5 secods for doctor`s interpretation